We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$14.6B
AUM Growth
-$1.02B
Cap. Flow
-$902M
Cap. Flow %
-6.19%
Top 10 Hldgs %
33.67%
Holding
1,168
New
194
Increased
342
Reduced
403
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$56M
2
CSCO icon
Cisco
CSCO
+$49.4M
3
META icon
Meta Platforms (Facebook)
META
+$45.4M
4
CVE icon
Cenovus Energy
CVE
+$40.5M
5
BNS icon
Scotiabank
BNS
+$39.8M

Sector Composition

Rank Sector Weight
1 Financials 27.48%
2 Energy 13.55%
3 Industrials 13.52%
4 Technology 10.79%
5 Materials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
426
Kimberly-Clark
KMB
$36.8B
$1.86M 0.01%
+13,075
New +$1.8M
CFR icon
427
Cullen/Frost Bankers
CFR
$10.5B
$1.85M 0.01%
20,950
+13,150
+169% +$1.17M
VICI icon
428
VICI Properties
VICI
$29.1B
$1.82M 0.01%
+80,300
New +$1.75M
NOC icon
429
Northrop Grumman
NOC
$81.7B
$1.81M 0.01%
+4,825
New +$1.71M
ATRO icon
430
Astronics
ATRO
$4.61B
$1.8M 0.01%
73,516
+19,126
+35% +$513K
AMCR icon
431
Amcor
AMCR
$21.5B
$1.78M 0.01%
+36,552
New +$1.89M
TIVO
432
DELISTED
Tivo Inc
TIVO
$1.77M 0.01%
232,004
+6,400
+3% +$48.9K
GPC icon
433
Genuine Parts
GPC
$18.7B
$1.76M 0.01%
17,725
-126,500
-88% -$12.1M
RTN
434
DELISTED
Raytheon Company
RTN
$1.75M 0.01%
8,900
-350
-4% -$64.8K
EGRX
435
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.74M 0.01%
30,733
-8,185
-21% -$460K
ALKS icon
436
Alkermes
ALKS
$8.32B
$1.73M 0.01%
+88,750
New +$1.93M
NGVC icon
437
Vitamin Cottage Natural Grocers
NGVC
$647M
$1.73M 0.01%
173,131
+17,775
+11% +$176K
RCKY icon
438
Rocky Brands
RCKY
$355M
$1.73M 0.01%
52,049
-4,901
-9% -$146K
SPPI
439
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1.73M 0.01%
208,350
+31,225
+18% +$253K
FIX icon
440
Comfort Systems
FIX
$60.6B
$1.72M 0.01%
38,792
-30,133
-44% -$1.31M
UNM icon
441
Unum
UNM
$14.7B
$1.72M 0.01%
57,750
-21,075
-27% -$626K
IHG icon
442
InterContinental Hotels
IHG
$23.5B
$1.71M 0.01%
27,407
+12,607
+85% +$823K
AR icon
443
Antero Resources
AR
$11.3B
$1.7M 0.01%
562,782
-113,695
-17% -$463K
NG icon
444
NovaGold Resources
NG
$3.42B
$1.7M 0.01%
279,568
+63,248
+29% +$415K
TLYS icon
445
Tilly's
TLYS
$123M
$1.69M 0.01%
179,407
-31,700
-15% -$280K
PBF icon
446
PBF Energy
PBF
$8.76B
$1.68M 0.01%
+61,925
New +$1.58M
SPTN
447
DELISTED
SpartanNash
SPTN
$1.68M 0.01%
141,975
+78,925
+125% +$888K
BNED icon
448
Barnes & Noble Education
BNED
$424M
$1.68M 0.01%
5,379
+569
+12% +$199K
STE icon
449
Steris
STE
$23.1B
$1.67M 0.01%
+11,575
New +$1.73M
PRU icon
450
Prudential Financial
PRU
$43B
$1.65M 0.01%
18,325
+10,425
+132% +$945K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2019 Portfolio in Review

As of Q3 2019, Connor, Clark & Lunn Investment Management (CC&L) held 1,168 positions worth $14.6B, down 6.5% from $15.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $902M in Q3 2019, closing 225 positions and reducing 403 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $37.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Fidelity National Information Services worth $29.9M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2019 buy was Fidelity National Information Services: 225,271 shares worth $29.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Pfizer in Q3 2019, an estimated $56M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2019 reduction was Toronto Dominion Bank, cutting an estimated $105M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Bristol-Myers Squibb in Q3 2019, selling an estimated $37.2M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 34% of its $14.6B portfolio in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 194 new positions and closed 225 in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 6.5% quarter-over-quarter to $14.6B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2019, filed 13 Nov 2019.